Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

Shares of companies developing psychedelic treatments jumped while those of vaccine makers slipped after a Senate committee advanced the nomination of Robert F. Kennedy Jr. to lead the Health and ...